Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells

Area of Science:

• Genomics
• Molecular Biology
• Bioinformatics

Background:

• Microarray technology has been the standard for transcriptome profiling.
• RNA sequencing (RNA-Seq) is an emerging technology for gene expression analysis.
• Direct comparison of RNA-Seq and microarray performance is crucial for understanding their respective strengths.

Purpose of the Study:

• To highlight the advantages of RNA-Seq over microarray for transcriptome profiling.
• To compare RNA-Seq and microarray performance using human T cell activation samples.
• To identify specific areas where RNA-Seq surpasses microarray technology.

Main Methods:

• RNA samples from a human T cell activation experiment were analyzed using both RNA-Seq and microarray (Affymetrix) platforms.
• Gene expression profiles from both platforms were compared.
• Key performance metrics including transcript detection, isoform differentiation, variant identification, and dynamic range were evaluated.

Main Results:

• Both platforms showed high correlation in gene expression profiles.
• RNA-Seq demonstrated superior sensitivity in detecting low abundance transcripts.
• RNA-Seq identified more differentially expressed genes with higher fold-change due to its broader dynamic range.
• RNA-Seq enabled better differentiation of critical isoforms and identification of genetic variants.
• RNA-Seq avoided microarray-specific technical issues like probe cross-hybridization and annotation limitations.

Conclusions:

• RNA-Seq offers significant advantages over microarrays in transcriptome profiling, including enhanced sensitivity, broader dynamic range, and improved variant detection.
• RNA-Seq overcomes inherent limitations of microarray probe-based detection.
• Despite current adoption barriers (cost, complexity, data storage), RNA-Seq is poised to become the dominant transcriptome analysis tool.